Tbx3 upregulation may be one of the malignant biomarkers of breast cancer.
- Author:
Zhong-hua CHEN
1
;
Guang-ming LV
;
Tian-hai JI
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; genetics; metabolism; Breast; cytology; metabolism; pathology; Breast Neoplasms; genetics; metabolism; pathology; Cell Line, Tumor; Humans; Immunohistochemistry; Middle Aged; Polymerase Chain Reaction; RNA, Messenger; genetics; metabolism; T-Box Domain Proteins; genetics; metabolism; Up-Regulation
- From: Journal of Southern Medical University 2009;29(4):765-767
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the role of abnormal Tbx3 expression in the pathogenesis of breast cancer.
METHODThe total RNA of 4 breast cancer cell lines and 5 normal breast samples was extracted by routine Trizol method. After reverse transcription of the total RNA into cDNA, Tbx3 mRNA expression was detected in these samples by real-time PCR. Immunohistochemistry was used to examine the differences in Tbx3 protein expression between 60 breast cancer samples and 34 normal breast tissue samples.
RESULTSCompared to normal breast tissue samples, the breast cancer cell lines showed markedly increased Tbx3 mRNA expression. The results of immunohistochemistry demonstrated a significant upregulation of Tbx3 protein expression in the 60 breast cancer tissues in comparison with the normal breast tissues, as was consistent with Tbx3 mRNA expressions in these tissue samples.
CONCLUSIONSThe mRNA and protein expressions of Tbx3 are markedly upregulated in breast cancer cell lines and tissue samples, suggesting that Tbx3 may serve as one of the malignant biomarkers in the pathogenesis of breast cancer.
